The countdown is on: from October 2–5, 2025, the international breast imaging community will gather in Aberdeen, Scotland for the EUSOBI Annual Scientific Meeting 2025. As every year, b-rayZ is proud to be part of this key event, showcasing how our AI-driven breast imaging solutions empower radiologists, technologists, and breast units worldwide.
Why EUSOBI 2025 Matters
The European Society of Breast Imaging (EUSOBI) conference is one of the most important gatherings in the field. Experts from across the globe come together to share the latest research, discuss clinical challenges, and discover new technologies shaping the future of breast cancer screening and diagnosis.
For us at b-rayZ, EUSOBI is more than an annual meeting – it’s the place to connect directly with breast imaging professionals, listen to their needs, and present how our solutions deliver value in daily practice.
For decades, Computer-Aided Detection (CAD) played a role in mammography, marking suspicious areas in 2D images. While CAD was a milestone, its shortcomings soon became clear: static algorithms, high false positives, and no integration into the broader clinical workflow.
Meanwhile, breast units today face mounting challenges:
- Increasing workloads and screening volumes.
- Complex modalities like synthetic 2D and digital breast tomosynthesis (DBT).
- The growing demand for risk-based, individualized screening.
CAD alone cannot meet these demands. That’s why b-rayZ developed our Pathfinder AI – a multi-modular, adaptive ecosystem guided by DANAI™, our adaptive AI engine.
Pathfinder AI – A New Era in Breast Imaging
Our software is a flexible platform that supports every stakeholder in the breast imaging pathway, from acquisition to reporting.
Key Principles
- Multi-Modular: Choose from independent modules – b-Quality, b-Density, b-Diagnostics, b-Smart, b-Risk – or deploy them as a suite.
- Adaptive AI (DANAI™): Learns continuously, adapting to guidelines, practice, and institutional needs.
- End-to-End Coverage: Goes beyond detection to quality, density, diagnosis, workflow, and risk prediction.
- Stakeholder-Centric: Radiologists, radiographers, program leaders, and patients all benefit.
The Modules in Focus
- b-Quality: Real-time image quality assessment (PGMI/PAI) with immediate feedback for technologists.
- b-Density: Automated, standardized BI-RADS density scoring for reliable stratification.
- b-Diagnostics: AI assistant for lesion and microcalcification detection in 2D, synthetic 2D, priors, and DBT.
- b-Smart: Workflow and performance dashboards for program leaders and administrators.
- b-Risk: Individualized risk prediction combining density, history, and patient factors.
Why our Pathfinder AI Stands Apart
Unlike CAD, our AI is:
- Dynamic, not static – adaptive to each environment.
- Modular, not monolithic – scalable to needs.
- End-to-end, not detection-only – covering acquisition, quality, density, diagnosis, workflow, and risk.
- Aligned with radiologists – using BI-RADS frameworks and real clinical logic.
- Future-ready – built for DBT, synthetic 2D, and personalized screening.
See it in action at EUSOBI 2025
Join us at Booth M4. Our team will provide:
- Hands-on demos of AI modules.
- Real-world case studies from European breast units.
- Discussions on the future of breast cancer screening, including risk-based approaches and AI integration.
Shaping the Future Together
The shift from population-based screening to personalized breast care is already underway. We are uniquely positioned to guide this transition, helping improve today’s workflows while preparing for tomorrow’s challenges.
👉 Visit us at EUSOBI 2025 in Aberdeen and discover how b-rayZ can empower your breast unit. Find out more about the congress here: https://www.eusobi.org/congress/
